Phase 1 7 trials
Phase 1
NCT05556798 Oct 2022 → Oct 2026 expected plasma cell myeloma Memorial Sloan Kettering Cancer Center
Active not recruiting
No outcome recorded
Phase 1
NCT05137054 Aug 2022 → Mar 2028 expected plasma cell myeloma Regeneron Pharmaceuticals
Recruiting
No outcome recorded
Phase 1
NCT04171843 Apr 2020 → Oct 2022 refractory plasma cell neoplasm Precision BioSciences, Inc.
Terminated
No outcome recorded
Phase 1
NCT04093596 Sep 2019 → Jan 2025 refractory plasma cell neoplasm Allogene Therapeutics
Completed
No outcome recorded
Phase 1
NCT02462707 Jul 2015 → Jun 2016 cancer Pfizer
Withdrawn
No outcome recorded
Phase 1
NCT01876251 Nov 2013 → Dec 2015 breast carcinoma Pfizer
Terminated
No outcome recorded
Phase 1
NCT00878189 Jun 2009 → Jan 2013 neoplasm Pfizer
Completed
No outcome recorded
Phase 1/2 2 trials
Phase 1/2
NCT07084896 Jun 2020 → Apr 2025 overdue plasma cell myeloma GlaxoSmithKline
Active not recruiting
No outcome recorded
Phase 1/2
NCT04126200 Oct 2019 → Apr 2025 overdue plasma cell myeloma GlaxoSmithKline
Active not recruiting
No outcome recorded
Phase 2 12 trials
Phase 2
NCT07539454 Sep 2026 → Feb 2030 expected Kaposi's sarcoma AIDS Malignancy Consortium
Not yet recruiting
No outcome recorded
Phase 2
NCT07170644 Aug 2025 → May 2027 expected desmoid tumor SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Active not recruiting
No outcome recorded
Phase 2
NCT05879146 Nov 2024 → Jan 2027 expected neoplasm M.D. Anderson Cancer Center
Recruiting
No outcome recorded
Phase 2
NCT05949099 Aug 2023 → Feb 2028 expected desmoid tumor Nam Bui
Recruiting
No outcome recorded
Phase 2
NCT05348356 Aug 2022 → Jul 2025 ovarian cancer , ovarian granulosa cell tumor SpringWorks Therapeutics, Inc.
Completed
No outcome recorded
Phase 2
NCT05090566 Oct 2021 → Feb 2025 plasma cell myeloma Pfizer
Terminated
No outcome recorded
Phase 2
NCT04195399 Oct 2020 → Mar 2026 overdue desmoid tumor Children's Oncology Group
Active not recruiting
No outcome recorded
Phase 2
NCT02137564 Jul 2015 HIV infectious disease , Kaposi's sarcoma AIDS Malignancy Consortium
Withdrawn
No outcome recorded
Phase 2
NCT02338531 Jun 2015 → Sep 2018 breast cancer Jules Bordet Institute
Withdrawn
No outcome recorded
Phase 2
NCT02299635 Feb 2015 → Jan 2016 triple-negative breast carcinoma Pfizer
Terminated
No outcome recorded
Phase 2
NCT02109445 Sep → Nov 2014 malignant pancreatic neoplasm Pfizer
Terminated
No outcome recorded
Phase 2
NCT01981551 Oct 2013 → Dec 2018 desmoid tumor National Cancer Institute (NCI)
Completed
No outcome recorded
Show 2 more trials Phase 3 1 trial
Phase 3
NCT03785964 Apr 2019 → Apr 2022 desmoid tumor SpringWorks Therapeutics, Inc.
Completed
No outcome recorded
Phase 4 1 trial
Phase 4
NCT07176689 Sep 2025 → Jan 2031 expected desmoid tumor SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Recruiting
No outcome recorded
Phase not stated 2 trials
— NCT05041036 — desmoid tumor SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Available
No outcome recorded
— NCT02955446 — desmoid tumor University of Colorado, Denver
No longer available
No outcome recorded